Geron Corp. (GERN)
1.665
+0.02
(+0.91%)
USD |
NASDAQ |
Mar 17, 10:03
Geron EPS Diluted (Quarterly) : -0.0467 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -1.414 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.14M |
| Revenue (Quarterly) | 48.02M |
| Total Expenses (Quarterly) | 79.16M |
| Enterprise Value | 948.67M |
| Gross Profit Margin (Quarterly) | 97.28% |
| Profit Margin (Quarterly) | -64.86% |
| Earnings Yield | -7.73% |
| Normalized Earnings Yield | -6.655 |